Home » Newsletters » BioWorld Science

BioWorld Science

April 3, 2020

View Archived Issues

Females, males have different metabolic response to intermittent fasting

First patient dosed in phase I/IIa study of TJC-4 in China

Positive data from investigator-initiated trial of DAS-181 for the treatment of COVID-19

Topline phase Ib/IIa results for AB-2004 in patients with ASD

Update on phase II study of ifenprodil in patients with COVID-19

Leronlimab shows potential immunological restoration in severely ill COVID-19 patients

Novel bleomycin-induced cynomolgus monkey model of IPF

Serum indoxyl sulfate as independent biomarker of arterial stiffness in CAD

Serum EV-Tspan8 level predicts distant metastasis in NSCLC

Silverback Therapeutics discloses new benzazepine compounds

ERN1 inhibitors discovered at Genentech

British American Tobacco announces work on potential vaccine for COVID-19

Roche identifies antagonists of Toll-like receptors

Crinetics Pharmaceuticals presents somatostatin SST2 receptor agonists

Terns synthesizes new ABL1/ABL2/Bcr-Abl inhibitors

Researchers develop a mouse model of 3q.29 deletion-driven psychiatric disorder

GigaGen developing recombinant polyclonal antibody therapy rCIG for COVID-19

New protein tau tracer [18F]THK-5562 developed for diagnosing Alzheimer's disease

X, Y copies of neuroligin-4 have different functions

Incyte and Novartis plan phase III evaluation of Jakavi for COVID-19-associated cytokine storm

Researchers create rat model of AKI to CKD progression

Vanda begins phase III study of tradipitant in hospitalized patients with COVID-19 pneumonia

FDA clears IND for phase I/II study of NK cell therapy CYNK-001 for COVID-19

European Commission approves rituximab biosimilar Ruxience

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...